Similar articles

• Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).

  Raggi P, Davidson M, Callister TQ, Welty FK, Bachmann GA, Hecht H, Rumberger JA. Raggi P, et al. Circulation. 2005 Jul 26;112(4):563-71. doi: 10.1161/CIRCULATIONAHA.104.512681. Epub 2005 Jul 11. Circulation. 2005. PMID: 16009795 Clinical Trial.
• Management of hyperlipidemia in the elderly population: an evidence-based approach.

  Dalal D, Robbins JA. Dalal D, et al. South Med J. 2002 Nov;95(11):1255-61. South Med J. 2002. PMID: 12539990 Review.
• Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.

  Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S. Schrott HG, et al. JAMA. 1997 Apr 23-30;277(16):1281-6. JAMA. 1997. PMID: 9109465
• Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.

  Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J. Pearson T, et al. Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28. Am J Geriatr Pharmacother. 2005. PMID: 16503317 Clinical Trial.
• High-dose statin therapy: benefits and safety in aggressive lipid lowering.

  Toth PP, Davidson MH. Toth PP, et al. J Fam Pract. 2008 May;57(5 Suppl High-Dose):S29-36. J Fam Pract. 2008. PMID: 18662521 Review. No abstract available.